A Risk Prediction Model for Evaluating the Disease Progression of COVID-19 Pneumonia

Guodong Cao,Pengping Li,Yuanyuan Chen,Kun Fang,Bo Chen,Shuyue Wang,Xudong Feng,Zhenyu Wang,Maoming Xiong,Ruiying Zheng,Mengzhe Guo,Qiang Sun
DOI: https://doi.org/10.3389/fmed.2020.556886
IF: 3.9
2020-11-05
Frontiers in Medicine
Abstract:<b>Background and Objective:</b> The epidemic of coronavirus disease 2019 (COVID-19) pneumonia caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) has expanded from China throughout the world. This study aims to estimate the risk of disease progression of patients who have been confirmed with COVID-19. <b>Methods:</b> Meta-analysis was performed in existing literatures to identify risk factors associated with COVID-19 pneumonia progression. Patients with COVID-19 pneumonia were admitted to hospitals in Wuhan or Hangzhou were retrospectively enrolled. The risk prediction model and nomogram were developed from Wuhan cohort through logistic regression algorithm, and then validated in Hangzhou and Yinchuan cohorts. <b>Results:</b> A total of 270 patients admitted to hospital between Dec 30, 2019, and Mar 30, 2020, were retrospectively enrolled (Table 1). The development cohort (Wuhan cohort) included 87 (43%) men and 115 (57%) women, and the median age was 53 years old. Hangzhou validation cohort included 20 (48%) men and 22 (52%) women, and the median age was 59 years old. Yinchuan validation cohort included 12 (46%) men and 14 (54%) women, and the median age was 44 years old. The meta-analysis along with univariate logistic analysis in development cohort have shown that age, fever, diabetes, hypertension, CREA, BUN, CK, LDH, and neutrophil count were significantly associated with disease progression of COVID-19 pneumonia. The model and nomogram derived from development cohort show good performance in both development and validation cohorts. <b>Conclusion:</b> The severe COVID-19 pneumonia is associated with various types of risk factors including age, fever, comorbidities, and some laboratory examination indexes. The model integrated with these factors can help to evaluate the disease progression of COVID-19 pneumonia.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to evaluate the risk of disease progression in patients diagnosed with Coronavirus Disease 2019 (COVID - 19). Specifically, the study aims to develop a prediction model to estimate the risk of patients developing severe COVID - 19 pneumonia by identifying risk factors associated with the progression of COVID - 19 pneumonia. This includes analyzing the impact of factors such as age, fever, diabetes, hypertension, creatinine (CREA), urea nitrogen (BUN), creatine kinase (CK), lactate dehydrogenase (LDH) and neutrophil count on disease progression. Through meta - analysis and multivariate logistic regression algorithms, combined with the clinical data of 270 COVID - 19 pneumonia patients collected in three regions, namely Wuhan, Hangzhou and Yinchuan, the study established a prediction model and a nomogram. The model was developed in the Wuhan cohort and validated in the Hangzhou and Yinchuan cohorts. The results show that the model has good predictive performance and can effectively evaluate the risk of disease progression in COVID - 19 pneumonia patients.